Evidence map›Paper›PMID 41948146›Full record

ArticleFrontiers in cardiovascular medicine2026

Is the effect of antihypertensive drug therapy on blood pressure control and prevalent cardiovascular disease associated with dietary sodium-potassium ratio? A cross-sectional study based on NHANES.

Ou Zhang, Yintang Wang, Yu Geng, Lei Bi, Boqun Shi, Yuhao Zhao, Xiaofan Wu

Abstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ou Zhang *Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Yintang Wang *Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Yu GengDepartment of Cardiology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
Lei BiDepartment of Cardiology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
Boqun ShiDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Yuhao ZhaoDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Xiaofan WuDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To evaluate whether antihypertensive treatment strategy and dietary sodium-to-potassium (Na/K) ratio are associated with blood pressure (BP) control and cardiovascular disease (CVD), and whether Na/K interacts with treatment effects. Methods: We analyzed 4,800 treated hypertensive adults (BP control defined as <130/80 mmHg) from NHANES 2009-2018 using survey-weighted logistic models and interaction analyses. Parallel endothelial experiments were performed in HUVECs exposed to normal or high Na/K, Ang II, and antihypertensive drugs. Results: Combination therapy was not associated with improved BP control (OR = 0.89; Conclusions: Pharmacologic treatment intensity and dietary Na/K ratio appeared to influence vascular outcomes independently in treated hypertension. Critically, the lack of dietary Na/K effect modification in the clinical population is biologically explained by the maintained drug efficacy under high Na/K conditions.

Indexed as

antihypertensive therapyblood pressure controlcardiovascular diseaseendothelial injuryhypertensionsodium-to-potassium ratio

Identifiers

PMID41948146
PMCPMC13050931

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.